Ampe investors have opportunity to lead ampio pharmaceuticals, inc. securities fraud lawsuit

Los angeles , sept. 13, 2022 /prnewswire/ -- glancy prongay & murray llp ("gpm") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ampio pharmaceuticals, inc. ("ampio" or the "company") (nyse: ampe).

AMPE Ratings Summary

AMPE Quant Ranking